SCHEMBL25920707

SCHEMBL25920707

N=Cc1ccccc1NC1CCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.49
GAA P10253 2/20 0.49
MAPT P10636 1/20 0.49
IDO1 P14902 1/20 0.40
HTR3E A5X5Y0 1/20 0.40
HTR3B O95264 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
HRH1 P35367 1/20 0.40
CHRNA7 P36544 1/20 0.40
CHRNA4 P43681 1/20 0.40
HTR3A P46098 1/20 0.40
TMEM97 Q5BJF2 1/20 0.40
HTR3D Q70Z44 1/20 0.40
HTR3C Q8WXA8 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23937823 0.92 KDM4E (0.43) KDM4EGAAMAPTIDO1HTR3E
SCHEMBL29952569 0.80 KDM4E (0.56) KDM4EGAAMAPTIDO1HSD17B10
SCHEMBL11521138 0.75 KDM4E (0.69) KDM4EGAAMAPTIDO1HSD17B10
SCHEMBL29449726 0.73 KDM4E (0.73) KDM4EGAAMAPTIDO1HSD17B10
SCHEMBL4495740 0.73 KDM4E (0.73) KDM4EGAAMAPTIDO1HSD17B10
SCHEMBL11523761 0.73 KDM4E (0.73) KDM4EGAAMAPTIDO1HSD17B10
SCHEMBL20336230 0.73 KDM4E (0.73) KDM4EGAAMAPTIDO1HSD17B10
SCHEMBL14185338 0.73 MAPT (0.37) KDM4EGAAMAPTIDO1HSD17B10
SCHEMBL24268721 0.71 MAPT (0.39) KDM4EGAAMAPTIDO1HSD17B10
SCHEMBL20333672 0.71 KDM4E (0.89) KDM4EGAAMAPTIDO1HTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed